Kiora Pharmaceuticals, Inc. (KPRX) Financials
KPRX Assets vs Liabilities
Date | Assets | Liabilities |
---|---|---|
2023-09-30 | 15.9 million | 7.8 million |
2023-06-30 | 19.9 million | 6.2 million |
2023-03-31 | 16.5 million | 6.4 million |
2022-12-31 | 18.7 million | 7.3 million |
KPRX Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
Date | Free Cash Flow | Stock based compensation |
---|---|---|
2023-09-30 | -2.5 million | 264864 |
2023-06-30 | -1.4 million | 171795 |
2023-03-31 | -3.1 million | 135941 |
2022-12-31 | -2.1 million | 45122 |
KPRX Net Income
No data available :(
KPRX Cash and Debt
Graph available only for supporters. Become a supporter to see it.
Date | Cash | Debt | Capital Lease |
---|---|---|---|
2023-09-30 | 5.4 million | - | 18725 |
2023-06-30 | 8.0 million | - | 39009 |
2023-03-31 | 3.4 million | - | 73289 |
2022-12-31 | 6.0 million | - | 105782 |
KPRX Shares Outstanding
KPRX Expenses
Graph available only for supporters. Become a supporter to see it.
Date | Capex | R&D | G&A | S&M |
---|---|---|---|---|
2023-09-30 | - | 1.1 million | 1.4 million | - |
2023-06-30 | - | 1.4 million | 1.1 million | - |
2023-03-31 | - | 438283 | 1.3 million | - |
2022-12-31 | - | 841617 | 2.8 million | - |
KPRX Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
Date | Revenue | Cost of Revenue |
---|---|---|
2023-09-30 | - | 42382 |
2023-06-30 | - | 56698 |
2023-03-31 | - | 42856 |
2022-12-31 | - | 10285 |
KPRX
Price: $0.51
52 week price:
Earnings Per Share: -2.69 USD
P/E Ratio: 0.85
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 47600
Market Capitalization: 15.1 million